InvestorsHub Logo
Post# of 252426
Next 10
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

Re: jbog post# 247514

Wednesday, 06/14/2023 7:49:46 PM

Wednesday, June 14, 2023 7:49:46 PM

Post# of 252426

In 2022/23 this class of patients weren't getting sick, they had the sniffles.



You seem to be ignoring the CDC recommendations about who should get prescribed Paxlovid even though I posted a link. Well, here is the link again so you can get accurate information.

https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/outpatient-treatment-overview.html

Here is what the CDC says.

What You Need to Know
There is strong scientific evidence that antiviral treatment of outpatients at risk for severe COVID-19 reduces their risk of hospitalization and death.

The antiviral drugs nirmatrelvir with ritonavir (Paxlovid) and remdesivir (Veklury) are the preferred treatments for eligible adult and pediatric patients who are at high risk for progression to severe COVID-19.

Clinicians should consider COVID-19 treatment in patients with mild-to-moderate COVID-19 who have one or more risk factors for severe COVID-19. Treatment must be started as soon as possible and within 5 days of symptom onset to be effective.



So what are the risk factors. Once again from the CDC link.

Risk Factors for Severe COVID-19
Clinicians can use the links below to identify patients at risk for severe COVID-19 and who may benefit from outpatient treatment. Severe outcomes of COVID-19 are defined as hospitalization, intensive care, ventilatory support, or death. There may be other medical conditions associated with severe COVID-19 not listed here, and clinical judgment is needed.

Age is the most important risk factor for severe outcomes of COVID-19.

Risk factors for severe COVID-19 include:

Age over 50 years, with risk increasing substantially at age ≥ 65 years

Being unvaccinated or not being up to date on COVID-19 vaccinations

Specific medical conditions and behaviors

Some people from racial and ethnic minority groups are at risk of being disproportionately affected by COVID-19 from many factors, including limited access to vaccines and healthcare.(1-3) Healthcare providers can consider these factors when evaluating the risk for severe COVID-19 and use of outpatient therapeutics.



As I said, this is a very large patient population. If you notice they didn't say take two Tylenol
or Advil and see me in the morning.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.